Pharmacological evaluation of new calcium antagonists: 2-substituted 3-dimethylamino-5,6-methylenedioxyindenes. Effects on adrenomedullary catecholamine secretion
Piascik, M.F.; Rahwan, R.G.; Witiak, D.T.
Journal of Pharmacology and Experimental Therapeutics 205(1): 155-163
1978
ISSN/ISBN: 0022-3565 PMID: 633080 Document Number: 126294
Document emailed within 1 workday
Related Documents
Schoenberger, J.A. 1988: Calcium antagonists: use in hypertension evaluation of calcium antagonists in combination with diuretics Angiology 39(1 Part 2): 87-93Ledda, F. 1978: Pharmacological assumptions in the use of calcium antagonists Bollettino Della Societa Italiana di Cardiologia 1978(1 Suppl): 10-13
Scriabine, A.; Kazda, S. 1989: Pharmacological basis for use of calcium antagonists in hypertension Magnesium 8(5-6): 253-265
Ivey, K.J. 1974: Control of gastric acid secretion by histamine H2-receptor antagonists; a pharmacological dream come true Australian and New Zealand Journal of Medicine 4(5): 521-524
Cui, Y.; Tan, Y.H. 1993: Effects of 3,6-dimethylamino-dibenzopyriodonium formiate on action potential and slow inward calcium current in isolated guinea pig ventricular myocytes Yao Xue Xue Bao 28(7): 504-506
Raddino, R.; Poli, E.; Pelà, G.; Ferrari, A.; Ghirarduzzi, A.; Ferrari, R. 1987: Effects of calcium antagonists on intracellular calcium deposits Cardiologia 32(4): 395-399
Tachikawa, E.; Takahashi, S.; Shimizu, C.; Ohtsubo, N.; Kashimoto, T.; Takahashi, E. 1984: Effects of nicardipine and other Ca2+-antagonists on catecholamine transport into chromaffin granule membrane vesicles Research Communications in Chemical Pathology and Pharmacology 45(2): 305-308
Ismail, N.A.; Shaheen, A.A.; el-Sawalhi, M.M.; Megahed, Y.M. 1995: Effect of calcium channel antagonists in modifying the inhibitory influence of adenosine on insulin secretion Arzneimittel-Forschung 45(8): 865-868
Gluhovschi, G.H.; Schiller, A.; Barbu, N. 1988: The effect of the association of calcium channel inhibitors with antagonists of H2 histamine receptors on the gastric secretion in duodenal ulcer patients Medecine Interne 26(3): 207-211
Viveros, O.H.; Diliberto, E.J.; Hazum, E.; Chang, K.J. 1980: Enkephalins as possible adrenomedullary hormones: storage, secretion, and regulation of synthesis Advances in Biochemical Psychopharmacology 22: 191-204
Nilsson, P. 2000: Impossible to document adverse effects of calcium antagonists. Effects equal to those of conservative treatment of hypertension Lakartidningen 97(35): 3710-3712
Horikawa, Y.; Nakajima, H.; Iizuka, K.; Imagawa, A.; Tomita, K.; Shiba, E.; Takai, S.; Miyagawa, J.; Kuwajima, M.; Namba, M.; Hanafusa, T.; Matsuzawa, Y. 1999: In vivo effects of calcium entry blockers on human parathyroid adenoma cells with special reference to calcium sensing ability and the hormone secretion Research Communications in Molecular Pathology and Pharmacology 106(1-2): 87-96
Ito, H.; Nakahara, K.; Sato, M.; Takada, N.; Hirakawa, S. 1983: Effects of calcium antagonists on mean circulatory pressure Nihon Rinsho. Japanese Journal of Clinical Medicine 41(12): 2709-2720
Furlanello, F.; Disertori, M.; Vergara, G.; Molinis, G.; Guarnerio, M.; Stefenelli, C. 1978: Electrophysiological effects of calcium-antagonists and their use in arrhythmia Bollettino Della Societa Italiana di Cardiologia 1978(1 Suppl): 60-78
Thuillez, C.; Giudicelli, J.F. 1981: Cardiovascular effects of calcium antagonists drug Therapie 36(2): 107-121
Gronowitz, S.; Svensson, L.; Stjernström, N.; Ogren, S.O. 1979: Thiophene-containing potentially neuroleptic rigid spiroamines. II. Synthesis of some N,N-dimethylamino-substituted spiro[H-cyclohepta[2,1-b;4,5-b]dithiophene-9,1'-cycloalkanes Acta Pharmaceutica Suecica 16(6): 365-375
Prado de Carvalho, L.; Venault, P.; Cavalheiro, E.; Kaijima, M.; Valin, A.; Dodd, R.H.; Potier, P.; Rossier, J.; Chapouthier, G. 1983: Distinct behavioral and pharmacological effects of two benzodiazepine antagonists: Ro 15-1788 and methyl beta-carboline Advances in Biochemical Psychopharmacology 38: 175-187
Fleckenstein-Grün, G.; Frey, M.; Thimm, F.; Fleckenstein, A. 1992: Protective effects of various calcium antagonists against experimental arteriosclerosis Journal of Human Hypertension 6(Suppl 1): S13-S18
Pastore, L.R.; Bartolo, M.; Penco, M.; Arata, L.; Di Renzi, L. 1979: Regional hemodynamic and metabolic effects of calcium antagonists Bollettino Della Societa Italiana di Cardiologia 24(8): 805-816
Mildenberger, D.; Klepzig, H.; Hopf, R.; Kaltenbach, M. 1989: The spectrum of side effects of gallopamil in comparison with other calcium antagonists Zeitschrift für Kardiologie 78(Suppl 5): 25-28